Evidence map›Paper›PMID 28597253›Full record

Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2017

Effectiveness of a standardized patient education program on therapy-related side effects and unplanned therapy interruptions in oral cancer therapy: a cluster-randomized controlled trial.

C Riese, B Weiß, U Borges, A Beylich, R Dengler, K Hermes-Moll, M Welslau, W Baumann

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. 15 years supporting adherence to oral anti-cancer treatment: use of the MASCC Oral Agent Teaching Tool (MOATT) worldwide, a review for the future.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Review
  7. Article
  8. Exploring Brachytherapy Discharge Educational Needs of Gynecological Cancer Patients.Journal of cancer education : the official journal of the American Association for Cancer Education · 2023
    Article
  9. An UHPLC-MS/MS method for quantification of the CDK4/6 inhibitor abemaciclib in human serum.Journal of mass spectrometry and advances in the clinical lab · 2022
    Article
  10. Article
  11. Improvement in adherence to Capecitabine and Lapatinib by way of a therapeutic education program.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
  12. New Oral Anti-Cancer Drugs and Medication Safety.Deutsches Arzteblatt international · 2019
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

C RieseScientific Institute of Office-Based Hematologists and Oncologists-WINHO, Vor den Siebenburgen 2, 50676, Cologne, Germany. riese@winho.de.ORCID http://orcid.org/0000-0002-5809-827X
B WeißInstitute of Sociology, University of Duisburg-Essen, Duisburg, Germany.
U BorgesScientific Institute of Office-Based Hematologists and Oncologists-WINHO, Vor den Siebenburgen 2, 50676, Cologne, Germany.
A BeylichHematological-Oncological Practice HOPA, Hamburg, Germany.
R DenglerHochschule für Oekonomie & Management (FOM), Institut für Gesundheit & Soziales (ifgs), Munich, Germany.
K Hermes-MollScientific Institute of Office-Based Hematologists and Oncologists-WINHO, Vor den Siebenburgen 2, 50676, Cologne, Germany.
M WelslauHematological-Oncological Practice, Aschaffenburg, Germany.
W BaumannScientific Institute of Office-Based Hematologists and Oncologists-WINHO, Vor den Siebenburgen 2, 50676, Cologne, Germany.
Chartered Institute for Archaeologists · GBFOM University of Applied Sciences for Economics and Management · DEGESIS - Leibniz-Institute for the Social Sciences · DEKlinikum Aschaffenburg · DESociety of Economic Geologists · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOral agents for cancer treatment are increasingly prescribed due to their benefits. However, oral cancer medications are difficult to handle and have a considerable potential for side effects. This type of therapy requires a high level of self-management competence by the patient. A standardized patient education program provided by physicians and oncology nurses may positively influence the handling of oral agents. The aim of the study was to evaluate the impact of a standardized patient education program provided by specially trained oncology nurses on therapy management regarding side effects and unplanned therapy interruptions.

methodsOne hundred sixty-five patients from 28 office-based oncology practices from all over Germany participated in this cluster-randomized controlled study. Patients of both intervention (n = 111) and standard care groups (n = 54) received the usual oncologist counseling; in addition, the patients from the intervention group (k = 17 practices) received an education from specially trained oncology nurses. The time of observation was 3 months per patient.

resultsThe patients of the intervention group reported fewer side effects (skin rash, pain, fatigue, nausea, vomiting). Patients in the standard care group interrupted the therapy more frequently without informing their oncologist, compared to the intervention group.

conclusionsPatients benefit from a standardized patient education program provided by specially trained oncology nurses. They tend to handle side effects and critical situations better.

Indexed as

AgedDrug-Related Side Effects and Adverse ReactionsFemaleHumansMaleMouth NeoplasmsPatient Education as TopicProspective StudiesSelf CareOncology nursesOral cancer therapyPatient educationTherapy-related side effectsUnplanned therapy interruption

Identifiers

PMID28597253
OpenAlexW2622223670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.